The Big Picture: China’s 2026 Foreign Investment Action Plan
On June 22, 2026, China’s Ministry of Commerce (MOFCOM), National Development and Reform Commission (NDRC), and Ministry of Finance jointly released the 2026 Action Plan for Stabilizing and Improving Foreign Investment Utilization — a 15-measure package aimed squarely at reversing two years of declining FDI inflows. China’s foreign direct investment fell 27% year-on-year in 2025, according to MOFCOM data, the steepest drop in a decade. This plan is Beijing’s response.
The plan addresses five priorities: market access, investment facilitation, investment promotion, service guarantees, and regulatory optimization. Unlike previous broad-stroke policy statements, this one reads like a checklist of specific fixes to problems foreign-invested enterprises (FIEs) have been raising for years — from restrictive cross-border data rules to M&A procedures that have not been meaningfully updated since 2006.
Here are the five measures that matter most for your business.
Financial Sector Access Gets Concrete
The plan commits to letting more foreign institutions use risk management tools, including treasury bond futures. It also permits qualified foreign institutions to conduct fund investment advisory business — a function previously limited to domestic players. For large FIEs, the plan introduces cross-border financing facilitation quotas and “proxy documentation” international settlement services through domestic banks.
Why this matters: Previous financial opening rounds focused on headline access — qualified investor schemes, bond market entry — while leaving day-to-day treasury friction untouched. This round targets operational bottlenecks. Companies weighing an onshore listing should start pre-application dialogue with exchanges now; early movers will benefit most from the “key enterprise” lists.
Pharma and Biotech Get Faster Market Access Pathways
The plan calls for implementing rules on segmented, cross-border production of biologics and chemical drugs by offshore marketing authorization holders. It also expands pilot zones for wholly foreign-owned hospitals and biotechnology, and encourages insurers to cover more innovative drugs and medical devices in commercial insurance plans.
Segmented production — splitting a drug’s manufacturing across facilities in different countries — has been constrained by China’s historical preference for localized production. If the implementing rules are favorable, foreign biopharma companies could serve the China market from existing overseas manufacturing networks without building full local production capacity. The wholly foreign-owned hospital pilots, floated since 2014, have expanded slowly — renewed commitment here suggests the pace may finally pick up.
The M&A Rules Get a Long-Overdue Rewrite
China’s core rules governing foreign acquisitions of domestic companies date to 2006 and have seen only limited updates since. The plan commits to accelerating a revision that streamlines M&A procedures, updates consideration and payment requirements, and strengthens regulator coordination.
Separately, qualified foreign equity investment institutions will be allowed to participate as strategic investors in securities issuances by listed companies outside their own industry — removing a requirement that strategic investors operate in a “related industry” to the target. This single change opens a genuinely new route into China’s listed-company market.
Foreign PE and strategic investors should revisit deals previously shelved solely because of the sector-relatedness rule, which has for years pushed investors into portfolio-style stakes rather than strategic ones when targets sat outside their core sector.
Cross-Border Data Moves Toward Negative Lists
FTZs and pilot cities for expanded services-sector opening are directed to develop “scenario-based, field-level” negative lists for data export, replacing the current uniform approach. In parallel, national standards are being developed to define “important data” catalogs by industry — covering manufacturing, telecoms, automotive, pharmaceuticals, aerospace, and civil aviation. For a deeper look at how these sector-specific lists work on the ground, see our guide to China’s evolving cross-border data rules.
China’s existing cross-border data transfer regime — security assessments, standard contracts, certification — has been criticized by foreign business for its broad, hard-to-scope definition of “important” data. Sector-specific negative lists would replace that uncertainty with narrower, more predictable compliance obligations. Data-intensive FIEs should watch which pilot cities publish lists first and consider routing data flows through FTZs once lists are in place. Qianhai, with its expanded tax incentives, is a particularly attractive FTZ for data-processing operations.
Reinvested Profits Gain Clearer Treatment
The plan reaffirms existing tax incentives for foreign investors who reinvest distributed profits into China, with instructions to ensure the benefit is “precisely delivered” rather than inconsistently applied. It also directs more reinvestment projects to be added to major and key foreign investment project lists, which come with expedited land, utility, and approval support.
Historically, priority project status skewed toward new greenfield investment, leaving reinvestment by existing FIEs comparatively underserved. Placing reinvestment on equal footing signals that Beijing wants existing investors to plow profits back into China rather than repatriate them. FIEs holding retained earnings onshore should model reinvestment structures now and apply for key project status where scale qualifies.
What You Should Do
- Financial institutions: Prepare cross-border financing quota requests with your lead bank. Early movers on “key enterprise” lists get the best terms.
- Pharma and biotech companies: Track the segmented-production implementing rules closely — publication is expected by Q4 2026.
- PE and strategic investors: Revisit M&A targets previously blocked by the industry-relatedness requirement.
- Data-intensive FIEs: Identify which FTZ pilot city — Qianhai, Lingang, or Tianjin — aligns with your data flows and register early. Qianhai in particular offers complementary tax incentives that make it an attractive base for data-processing operations.
- All FIEs with onshore retained earnings: Model reinvestment scenarios before year-end to qualify for priority project status.
One Data Point
The number to remember: 27% — that is how much China’s FDI dropped in 2025. The 2026 action plan is not a routine policy refresh; it is a response to a real capital flight problem, and the 15 measures are calibrated to address specific friction points that foreign investors have been naming for years.
According to China Briefing’s analysis, this plan reads “less like a policy wish list and more like a checklist of specific, implementable fixes” — a shift in approach that suggests the implementation pace may be faster than previous rounds of opening.
